Purple Biotech Ltd.PPBTNASDAQ
Loading
Year-over-year research & development expense growth
| Period | Value |
|---|---|
| Q3 2025 | 6.64% |
| Q2 2025 | -27.24% |
| Q1 2025 | 65.94% |
| Q4 2024 | -66.02% |
| Q3 2024 | -43.62% |
| Q2 2024 | -30.15% |
| Q1 2024 | -34.70% |
| Q4 2023 | 14.23% |
| Q3 2023 | 23.86% |
| Q2 2023 | 5.92% |
| Q1 2023 | -27.43% |
| Q4 2022 | 39.11% |
| Q3 2022 | 66.35% |
| Q2 2022 | -65.00% |
| Q1 2022 | 93.62% |
| Q4 2021 | 71.44% |
| Q3 2021 | -14.09% |
| Q2 2021 | -58.32% |
| Q1 2021 | 159.70% |
| Q4 2020 | -11.48% |
| Q3 2020 | 38.99% |
| Q2 2020 | 0.00% |
| Q1 2020 | 1515.46% |
| Q4 2019 | -80.32% |
| Q3 2019 | -41.59% |
| Q2 2019 | 0.00% |
| Q1 2019 | -30.42% |
| Q4 2018 | 0.00% |
| Q3 2018 | -14.64% |
| Q2 2018 | 0.00% |
| Q1 2018 | 33.80% |
| Q4 2017 | 0.00% |
| Q3 2017 | -15.58% |
| Q2 2017 | 0.00% |
| Q1 2017 | 13.54% |
| Q4 2016 | 0.00% |
| Q3 2016 | 12.83% |
| Q2 2016 | 0.00% |
| Q1 2016 | 33.61% |
| Q4 2015 | -18.87% |